INMED PHARMACEUTICALS INC (INM)
CA4576376012 - Common Stock
| TTM (2023-12-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -6.36M | -7.95M | -18.60M | -10.20M | -8.94M | |||
| Depreciation Amortization | 210.06K | 200.00K | 190.00K | 120.00K | 110.00K | |||
| Change In Working Capital | -746.12K | -570.00K | -3.07M | -540.00K | 290.00K | |||
| Interest Paid | N/A | N/A | N/A | 90.00K | 70.00K | |||
| Other non cash items | 538.73K | 1.03M | 5.90M | 840.00K | 1.17M | |||
| OPERATING CASH FLOW | -6.33M | -7.28M | -15.58M | -9.79M | -7.37M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -160.00K | -40.00K | 0.00 | -40.00K | |||
| Other Investing Activity | 0.00 | -500.00K | -630.00K | 0.00 | 3.83M | |||
| INVESTING CASH FLOW | -169.29K | -660.00K | -670.00K | 0.00 | 3.79M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -290.00K | N/A | -70.00K | |||
| Stock Issued/Repurchased | N/A | 12.00M | 17.15M | 12.47M | 0.00 | |||
| Other Financing Activity | 4.59M | -1.32M | -1.78M | -1.62M | -30.00K | |||
| FINANCING CASH FLOW | 4.59M | 10.68M | 15.07M | 10.85M | -30.00K | |||
| Exchange Rate Effect | N/A | N/A | 0.00 | 490.00K | -420.00K | |||
| CHANGE IN CASH | -1.91M | 2.74M | -1.18M | 1.55M | -4.03M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.33M | -7.28M | -15.58M | -9.79M | -7.37M | |||
| Capital Expenditure | N/A | -160.00K | -40.00K | 0.00 | -40.00K | |||
| FREE CASH FLOW | -6.50M | -7.44M | -15.62M | -9.79M | -7.41M | |||
All data in USD